AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Revenue
Transportation led with $58.55 million in revenue, followed by Industrial at $37.10 million. The Medical segment contributed $21.96 million, while Aerospace & Defense added $25.36 million. Total revenue reached $142.97 million, reflecting an 8.0% year-over-year increase driven by diversified market growth and the SyQwest acquisition.
Earnings/Net Income
Earnings per share (EPS) declined 21.7% to $0.47, down from $0.60 in 2024 Q3. Net income fell to $13.69 million, a 24.3% decrease from $18.08 million in the prior year. The EPS decline indicates a weak earnings performance despite revenue growth.
Post-Earnings Price Action Review
The strategy of buying
CEO Commentary
Kieran O’Sullivan, CEO, highlighted strong diversified market growth, with 59% of Q3 revenue from industrial, aerospace, and medical segments. He emphasized strategic acquisitions and new contracts, such as a $5 million naval defense project for SyQwest.
Guidance
For FY2025, CTS narrowed sales guidance to $535–$545 million and adjusted diluted EPS to $2.20–$2.25. The company expects margin compression in Q4 but remains optimistic about long-term growth in diversified markets.
Additional News
Recent updates include a narrowed FY2025 outlook, a $5 million naval defense contract win for SyQwest, and $44 million returned to shareholders via dividends and buybacks. The company also reported $110 million in cash reserves and $91 million in long-term debt. Supply chain risks, including rare earth and semiconductor constraints, remain under monitoring.
Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.

Dec.06 2025

Dec.06 2025

Dec.06 2025

Dec.06 2025

Dec.06 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet